scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0140-6736(06)69615-3 |
P698 | PubMed publication ID | 17071265 |
P50 | author | John Ioannidis | Q6251482 |
P2860 | cites work | Antibiotics for acute pyelonephritis in children | Q24244919 |
Indirect comparisons of competing interventions | Q28183606 | ||
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials | Q29619501 | ||
Better reporting of harms in randomized trials: an extension of the CONSORT statement | Q33983100 | ||
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement | Q33993977 | ||
Simultaneous comparison of multiple treatments: combining direct and indirect evidence. | Q34081552 | ||
Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer: biases and evolution over time | Q35558566 | ||
Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials | Q35629103 | ||
Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses | Q36637482 | ||
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses | Q39735046 | ||
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. | Q50145200 | ||
Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis | Q53877989 | ||
Network meta-analysis for indirect treatment comparisons | Q74720205 | ||
P433 | issue | 9546 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1470-1472 | |
P577 | publication date | 2006-10-01 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Indirect comparisons: the mesh and mess of clinical trials | |
P478 | volume | 368 |
Q94445656 | A Bayesian approach to discrete multiple outcome network meta-analysis |
Q35237327 | A pragmatic view on pragmatic trials |
Q40956038 | An alternative parameterization of Bayesian logistic hierarchical models for mixed treatment comparisons |
Q35553233 | An assessment of the methodological quality of published network meta-analyses: a systematic review |
Q38520487 | Assessing key assumptions of network meta-analysis: a review of methods |
Q43058828 | Bias in identification of the best treatment in a Bayesian network meta-analysis for binary outcome: a simulation study |
Q84975716 | Calculating additive treatment effects from multiple randomized trials provides useful estimates of combination therapies |
Q37897625 | Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis. |
Q37133396 | Direct versus indirect comparisons: a summary of the evidence |
Q46609331 | Economic evaluation of Sinfrontal in the treatment of acute maxillary sinusitis in adults |
Q21093304 | Effectiveness of smoking cessation therapies: a systematic review and meta-analysis |
Q36966424 | Evaluation of networks of randomized trials |
Q38005597 | Evidence-based surgery: barriers, solutions, and the role of evidence synthesis |
Q37832531 | Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis |
Q24236814 | Fluvoxamine versus other anti-depressive agents for depression |
Q37764847 | Frequency of treatment-effect modification affecting indirect comparisons: a systematic review |
Q30251972 | GetReal in network meta-analysis: a review of the methodology |
Q57542870 | Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool |
Q37572176 | Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses |
Q46894544 | Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1 |
Q30578166 | Meta-analysis of clinical trial safety data in a drug development program: Answers to frequently asked questions |
Q33403399 | Metastatic renal cell cancer treatments: an indirect comparison meta-analysis |
Q37433313 | Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews |
Q24240125 | Milnacipran versus other antidepressive agents for depression |
Q24234046 | Mirtazapine versus other antidepressive agents for depression |
Q35089776 | Multiple treatment comparison meta-analyses: a step forward into complexity. |
Q37344525 | Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer |
Q47131728 | Network meta-analysis: application and practice using Stata |
Q35014739 | Nevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trials |
Q38069844 | Preservation Solutions for Liver Transplantation in Adults: Celsior versus Custodiol: A Systematic Review and Meta-analysis With an Indirect Comparison of Randomized Trials |
Q37129735 | Progress update: Pharmacological treatment of Alzheimer's disease. |
Q42748619 | Quantifying nonsteroidal anti-inflammatory drug (NSAID) risk: can combining the evidence with the use of a network meta-analysis provide a solution? |
Q37195565 | Reasons or excuses for avoiding meta-analysis in forest plots |
Q28291828 | Secondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple-treatments meta-analysis |
Q46987043 | Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis |
Q37641067 | The use of older studies in meta-analyses of medical interventions: a survey. |
Q64247210 | Tramadol/dexketoprofen (TRAM/DKP) compared with tramadol/paracetamol in moderate to severe acute pain: results of a randomised, double-blind, placebo and active-controlled, parallel group trial in the impacted third molar extraction pain model (DAVID |
Q39022643 | Treatment decisions in multiple sclerosis - insights from real-world observational studies. |
Q38524041 | Use of indirect comparison methods in systematic reviews: a survey of Cochrane review authors. |
Q51924377 | Validity of indirect comparisons in meta-analysis. |
Q54635351 | ["Be careful with indirect comparisons: the case of the new oral anticoagulants"]. |
Q82862517 | [Closing evidence gaps] |
Search more.